Program Goals

This program is designed to improve clinical awareness of the fragile X syndrome (FXS) and in particular the role the causative gene FMR1 plays in premature ovarian failure. Historical and updated findings concerning the syndrome and FMR1 will be presented, along with requirements for accurate laboratory tests. Special emphasis is placed on the relationship between fragile X status (number of CGG repeats) and premature ovarian failure (POF), and strategy for prenatal genetic diagnosis.

Target Audience

Obstetricians/Gynecologists, Ph.D. Clinical Geneticists, M.D. Medical Geneticists, Genetic Counselors, Pediatricians, Nurses, Mental Health Specialists, Laboratory Professionals, and related healthcare professionals interested or involved in the clinical management of fragile X syndrome (FXS).

Educational Objectives

After completing this activity, the participant should be able to:

1. Explain why disturbances of the FMR1 gene less frequently cause mental retardation in females than males.
2. Define premutation with respect to Fragile X syndrome and its (FMR1) gene.
3. Describe how a carrier (premutation) having 55-199 CGG repeats can have offspring with mental retardation.
4. State the likelihood of a sporadic or familial case of POF showing a premutation.
5. Discuss the relationship of POF to number of CGG repeats.

Faculty

Joe Leigh Simpson, MD

Kenneth J. Friedman, PhD

CME (ACCME) Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Collaborative (MEC) and Dane Garvin Ltd. Medical Education Collaborative is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation – Physician, CME

Medical Education Collaborative designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For any questions concerning the accreditation of this activity, please contact Medical Education Collaborative at (866) 420-3252.

Credit Designation – Lab Professional, P.A.C.E.^®

The American Society for Clinical Laboratory Science’s Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 1.5 contact hour of credit

Commercial Support Statement

This activity is supported by an educational grant from Abbott Molecular.

Disclosure of Conflicts of Interests

Instructors, planners, managers and other individuals who are in a position to control the content of this activity are required to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. In this activity, the faculty discloses that they will not discuss any unlabeled use of drugs, devices, or procedures nor investigational products or procedures.

Faculty Disclosures

Name	Type	Commercial Supporter
Joe Leigh Simpson, MD	N.A.	N.A.
Kenneth J. Friedman, PhD	N.A.	N.A.

Employees of Medical Education Collaborative, the accredited provider for this activity, have disclosed that they have no significant financial relationships.

Faculty Disclosure Summary

Medical Education Collaborative adheres to ACCME Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, are made known above.

Dane Garvin Ltd. Disclosure

Dane Garvin, the joint sponsor for this activity, has disclosed they have no significant financial relationships.

Policy on Privacy and Confidentiality

Medical Education Collaborative (MEC) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MEC and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Medical Education Collaborative (MEC) Dane Garvin, Ltd. maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

How to Obtain CME Credit

Viewers are expected to visit all presentations before attempting to take the test and activity evaluation. Successful completion will lead to the issuance of a certificate for 1.5 AMA PRA Category 1 Credit(s) ™. To receive credit, the course must be completed before March 31, 2009.

If you attended the live presentation on February 28, 2008 and have received CME credit for this program, you are not eligible for additional credit.

Participation in this activity should be completed in approximately 1.5 hours. Please follow these steps in order to receive CME credit for viewing the webcast:

• Read all of the CME accreditation information above.
• View the complete webcast program.
• Click on the link to apply for CME credits.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.
• After successfully completing the online test and evaluation, your application will be processed by the CME provider and your certificate will be sent to you. Please allow 3-4 weeks for this process.

Should you have any CME questions regarding this activity, please contact:
Medical Education Collaborative
651 Corporate Circle, Suite 104
Golden, CO 80401
866.420.3252 (toll free)
303.420.3259 (fax)
http://www.meccme.org/

How to Obtain P.A.C.E.^® Credit

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.5 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed before March 31, 2009. No post-test is required through September 30, 2008; after that date a quiz must be completed to earn credit.

If you attended the live presentation on February 28, 2008, and have already received P.A.C.E.® credit for this program, you are not eligible for additional credit.

Participation in this activity should be completed in approximately 1.5 hours. Please follow these steps in order to receive P.A.C.E.® credit for viewing the webcast:

• Read all of the information above.
• View the complete webcast program.
• Click on the link to apply for P.A.C.E.® credit.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 75% (if taken after September 30, 2008) and answer all evaluation questions to receive a certificate.
• After successfully completing the online test and/or evaluation, your application will be processed by the CE provider and your certificate will be sent to you via email. Please allow 3-4 weeks for this process.

Should you have any P.A.C.E.® questions regarding this activity, please contact:
ASCLS P.A.C.E.®
6701 Democracy Blvd., Suite 300
Bethesda, MD 20817-1574
Ph: 301-657-2768
Fx: 301-657-2909
http://www.ascls.org/

For technical difficulties, please consult our Technical Instructions.

Release Date: March 31, 2008
Expiration date: March 31, 2009

MEC serial number: #7467

Click here to view the web conference

Medium Used

This program has been made available online.
"Fragile X Syndrome: Premature Ovarian Failure and Molecular Diagnosis"

Legal Disclaimer

The opinions expressed in this educational activity are those of the faculty and do not reflect the views of Medical Education Collaborative and Dane Garvin, Ltd. This educational activity may discuss off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug Administration (FDA). Medical Education Collaborative and Dane Garvin, Ltd. do not recommend the use of any product/procedure outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product/procedure discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity. Please refer to the official prescribing information for each product/procedures for approved indication, contraindications, and warnings.

Copyright

Copyright © March 31, 2008 - March 31, 2009 Dane Garvin, Ltd. All Rights Reserved. Permission for accreditation use granted to Medical Education Collaborative (MEC).